Tweets by IDWeek 2023

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

346 Views

047. COVID-19: Treatment: Thursday, 12:15 - 1:30 p.m.

Poster Session: COVID-19: Treatment

(545) Remdesivir And Obeldesivir Retain Potent Activity Against SARS-CoV-2 Omicron Variants

Thursday, October 12, 2023

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Presenting Author(s)

Lauren Rodriguez, PhD

Research Scientist
Gilead Sciences, Inc.
Foster City, California, United States

JL

Jiani Li, PhD

Gilead Sciences, Inc.
Foster City, California, United States
DH

Dong Han, MS

Gilead Sciences, Inc.
Foster City, California, United States
RM

Ross Martin, PhD

Sr Research Scientist II
Gilead Sciences
Foster City, California, United States
JM

Jasmine Moshiri, PhD

Gilead Sciences, Inc.
Foster City, California, United States
NP

Nadine Peinovich, MPH

Gilead Sciences, Inc.
Foster City, California, United States
JB

John P. Bilello, PhD

Gilead Sciences, Inc.
Foster City, California, United States
JP

Jason K. Perry, PhD

Gilead Sciences, Inc.
Foster City, California, United States
Charlotte Hedskog, PhD (she/her/hers)

Senior Research Scientist
Gilead Sciences, Inc.
Foster City, California, United States